Tenon Medical, Inc. ( (TNON) ) has released its Q3 earnings. Here is a breakdown of the information Tenon Medical, Inc. presented to its investors.
Looking forward, Tenon Medical remains optimistic about its growth prospects. The company is focusing on leveraging its recent clinical data and new product introductions to drive future revenue growth. With the full commercial launch of the Catamaran SE SI Joint Fusion System expected in early 2025, Tenon aims to continue its trajectory of innovation and expansion in the SI joint treatment market.
